• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Kristen Evaul, Michelle Jamnongjit, Bala Bhagavath, Stephen R. Hammes
  • Biology, Medicine
  • Molecular endocrinology
  • 2007
  • Many transcription-independent (nongenomic) steroid effects are regulated by G proteins. A well-established, biologically relevant example of steroid/G protein interplay is steroid-triggered oocyteContinue Reading
  • Kristen Evaul, Rui Li, Mahboubeh Papari-Zareei, Richard J. Auchus, Nima Sharifi
  • Biology, Medicine
  • Endocrinology
  • 2010 (First Published: 1 August 2010)
  • Prostate cancer usually responds to androgen deprivation therapy, although the response in metastatic disease is almost always transient and tumors eventually progress as castration-resistantContinue Reading
  • Rui Li, Kristen Evaul, +5 authors Nima Sharifi
  • Biology, Medicine
  • Clinical cancer research : an official journal of…
  • 2012 (First Published: 1 July 2012)
  • PURPOSE Treatment with abiraterone (abi) acetate prolongs survival in castration-resistant prostate cancer (CRPC). Resistance to abi invariably occurs, probably due in part to upregulation ofContinue Reading
  • Nima Sharifi, Rui Li, Kristen Evaul, Kamalesh K Sharma, Richard J. Auchus
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2012
  • 209 Background: Treatment with abiraterone acetate (abi) increases the survival of men with castration-resistant prostate cancer (CRPC). Resistance to abi invariably occurs, probably due in part toContinue Reading
  • Nima Sharifi, Rui Li, Kristen Evaul, Kamalesh K Sharma, Richard J. Auchus
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2012 (First Published: 10 February 2012)
  • 209 Background: Treatment with abiraterone acetate (abi) increases the survival of men with castration-resistant prostate cancer (CRPC). Resistance to abi invariably occurs, probably due in part toContinue Reading